文献速递慢性肾脏病肾血管病与高血压

非酒精性脂肪性肝病与慢性肾脏病临床结局

Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

该研究在1148例晚期CKD患者中评估NAFLD患病率及其对心血管事件、终末期肾病和死亡的影响。NAFLD患病率为17.9%,中位随访5.4年,NAFLD是心血管事件的独立危险因素(HR 2.03),但与全因死亡和CKD进展无关。倾向匹配分析显示NAFLD增加心血管风险(HR 2.00)。

要点

  • 晚期CKD患者中NAFLD患病率为17.9%。
  • NAFLD与心血管事件独立相关(HR 2.03),倾向匹配后仍显著(HR 2.00)。
  • NAFLD与全因死亡及CKD进展无显著关联。

核心结论

  • NAFLD与心血管事件独立相关,即使在合并症较多的晚期CKD队列中也是如此。

研究设计与样本

  • 研究纳入1148例接受过肝脏超声检查的CKD患者,来自一个3061例CKD患者的队列,随访15年,并包含倾向匹配人群。

主要发现

  • NAFLD患病率为17.9%,扫描后中位随访5.4年,中位eGFR为33.5 mL/min/1.73 m2。
  • NAFLD是心血管事件的独立危险因素(HR 2.03;95%CI 1.33-3.13;P<0.01)。
  • NAFLD与全因死亡无关(HR 0.79;95%CI 0.58-1.08;P=0.14),与CKD进展无关(eGFR下降斜率P=0.09)。
  • 倾向匹配分析显示NAFLD增加心血管风险(HR 2.00;95%CI 1.10-3.66;P<0.05)。

临床怎么用

  • 在CKD人群中常规筛查NAFLD可能有助于识别心血管高危患者并实施针对性预防干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is an independent risk factor associated with cardiovascular disease (CVD) and incidence of chronic kidney disease (CKD). NAFLD is threatening to become a major public health problem in association with the metabolic syndrome. The association of NAFLD with outcomes in patients with advanced CKD has not been evaluated. In this study, the prevalence of NAFLD and its impact on cardiovascular and renal outcomes and mortality were determined in a large secondary care CKD cohort. METHODS: The study was conducted on 1148 CKD patients within a cohort of 3061 CKD patients, who had undergone ultrasound imaging of the liver over a 15-year period. A propensity-matched population from within the cohort was also included. Cox regression analysis was used to study the association of NAFLD with cardiovascular events, end-stage renal disease and mortality and linear regression analysis for CKD progression. RESULTS: The prevalence of NAFLD was 17.9%. The median duration of follow-up after scanning was 5.4 years, with a median estimated glomerular filtration rate (eGFR) of 33.5 mL/min/1.73 m2 in this population. NAFLD proved to be a strong independent risk factor for cardiovascular events [hazard ratio (HR) 2.03; 95% confidence interval (CI) 1.33-3.13; P < 0.01] but it was not associated with all-cause mortality (HR 0.79; 95% CI 0.58-1.08; P = 0.14) or CKD progression (P = 0.09 for rate of decline of eGFR slope). Patients with CKD are known to have high cardiovascular risk; the propensity-matched analysis showed that NAFLD increased this cardiovascular risk (HR 2.00; CI 1.10-3.66; P < 0.05). CONCLUSIONS: NAFLD has a strong independent association with cardiovascular events, even in an advanced CKD cohort with high comorbidity. The implication is that routine screening for NAFLD may be warranted in CKD populations to enable targeted interventions for CVD prevention in higher risk patients.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Chinnadurai R, Ritchie J, Green D, et al. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. Nephrol Dial Transplant. 2019. PMID: 29390103. doi:10.1093/ndt/gfx381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。